Nephrin mutations cause childhood- and adult-onset focal segmental glomerulosclerosis
Author(s) -
Sheila Santín,
Rafael GarcíaMaset,
Patricia Ruíz,
Isabel Giménez,
I. Zamora,
Antonia Peña,
A. Madrid,
Juan Antonio Camacho,
Gloria Fraga,
Ana SánchezMoreno,
María Ángeles Cobo,
Carmen Bernis,
Alberto Ortíz,
Augusto Luque de Pablos,
Guillem PintosMorell,
Maria Luisa Justa,
Emilia Hidalgo-Barquero,
Patricia FernándezLlama,
José Ballarín,
Elisabet Ars,
Roser Torrá,
on behalf of the FSGS Spanish Study Group
Publication year - 2009
Publication title -
kidney international
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.499
H-Index - 276
eISSN - 1523-1755
pISSN - 0085-2538
DOI - 10.1038/ki.2009.381
Subject(s) - focal segmental glomerulosclerosis , nephrotic syndrome , nephrin , minimal change disease , congenital nephrotic syndrome , mutation , age of onset , compound heterozygosity , medicine , glomerulonephritis , slit diaphragm , genetics , disease , biology , podocyte , gene , kidney , proteinuria
Mutations in the NPHS1 gene cause congenital nephrotic syndrome of the Finnish type presenting before the first 3 months of life. Recently, NPHS1 mutations have also been identified in childhood-onset steroid-resistant nephrotic syndrome and milder courses of disease, but their role in adults with focal segmental glomerulosclerosis remains unknown. Here we developed an in silico scoring matrix to evaluate the pathogenicity of amino-acid substitutions using the biophysical and biochemical difference between wild-type and mutant amino acid, the evolutionary conservation of the amino-acid residue in orthologs, and defined domains, with the addition of contextual information. Mutation analysis was performed in 97 patients from 89 unrelated families, of which 52 presented with steroid-resistant nephrotic syndrome after 18 years of age. Compound heterozygous or homozygous NPHS1 mutations were identified in five familial and seven sporadic cases, including one patient 27 years old at onset of the disease. Substitutions were classified as 'severe' or 'mild' using this in silico approach. Our results suggest an earlier onset of the disease in patients with two 'severe' mutations compared to patients with at least one 'mild' mutation. The finding of mutations in a patient with adult-onset focal segmental glomerulosclerosis indicates that NPHS1 analysis could be considered in patients with later onset of the disease.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom